Novo Nordisk AS
A3EU6F
DK0062498333 //
Quelle: CPH Equities: --
298,50 DKK
Kurs
Kurs
-2,12%
Diff. Vortag in %
Diff. Vortag in %
224,25 DKK
52 Wochen Tief
52 Wochen Tief
409,95 DKK
52 Wochen Hoch
52 Wochen Hoch
- Neutral
- Seit dem 07.07.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 0 Monate | 0 Monate | 298,50 265 | 298,50 | 265 | 11,222781 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12 Monate | 12 Monate | 298,50 290 | 298,50 | 290 | 2,847571 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 24.08.2026 0 Monate | 24.08.2026 | 0 Monate | 298,50 275 | 298,50 | 275 | 7,872697 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 298,50 290 | 298,50 | 290 | 2,847571 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.08.2026 0 Monate | 11.08.2026 | 0 Monate | 298,50 305 | 298,50 | 305 | 2,177554 | BERENBERG | ||
| Novo Nordisk AS | 07.08.2026 0 Monate | 07.08.2026 | 0 Monate | 298,50 | 298,50 | -- | DZ BANK | |||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 298,50 285 | 298,50 | 285 | 4,522613 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.08.2026 12 Monate | 06.08.2026 | 12 Monate | 298,50 290 | 298,50 | 290 | 2,847571 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 298,50 200 | 298,50 | 200 | 32,998325 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.08.2026 0 Monate | 05.08.2026 | 0 Monate | 298,50 332 | 298,50 | 332 | 11,222781 | UBS | ||
| Novo Nordisk AS | 05.08.2026 12 Monate | 05.08.2026 | 12 Monate | 298,50 310 | 298,50 | 310 | 3,852596 | BARCLAYS | ||
| Novo Nordisk AS | 04.08.2026 12 Monate | 04.08.2026 | 12 Monate | 298,50 285 | 298,50 | 285 | 4,522613 | JEFFERIES |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 04.08.2026 0 Monate | 04.08.2026 | 0 Monate | 298,50 332 | 298,50 | 332 | 11,222781 | UBS | ||
| Novo Nordisk AS | 31.07.2026 0 Monate | 31.07.2026 | 0 Monate | 298,50 250 | 298,50 | 250 | 16,247906 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 298,50 290 | 298,50 | 290 | 2,847571 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.07.2026 0 Monate | 10.07.2026 | 0 Monate | 298,50 332 | 298,50 | 332 | 11,222781 | UBS | ||
| Novo Nordisk AS | 29.06.2026 12 Monate | 29.06.2026 | 12 Monate | 298,50 285 | 298,50 | 285 | 4,522613 | JEFFERIES | ||
| Novo Nordisk AS | 28.06.2026 0 Monate | 28.06.2026 | 0 Monate | 298,50 250 | 298,50 | 250 | 16,247906 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 298,50 290 | 298,50 | 290 | 2,847571 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.06.2026 0 Monate | 16.06.2026 | 0 Monate | 298,50 325 | 298,50 | 325 | 8,877722 | BERENBERG | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 298,50 290 | 298,50 | 290 | 2,847571 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 298,50 250 | 298,50 | 250 | 16,247906 | JPMORGAN | ||
| Novo Nordisk AS | 08.06.2026 0 Monate | 08.06.2026 | 0 Monate | 298,50 250 | 298,50 | 250 | 16,247906 | JPMORGAN | ||
| Novo Nordisk AS | 03.06.2026 12 Monate | 03.06.2026 | 12 Monate | 298,50 305 | 298,50 | 305 | 2,177554 | GOLDMAN SACHS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 29.05.2026 0 Monate | 29.05.2026 | 0 Monate | 298,50 270 | 298,50 | 270 | 9,547739 | JEFFERIES | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 298,50 290 | 298,50 | 290 | 2,847571 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 298,50 290 | 298,50 | 290 | 2,847571 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 18.05.2026 0 Monate | 18.05.2026 | 0 Monate | 298,50 300 | 298,50 | 300 | 0,502513 | BARCLAYS | ||
| Novo Nordisk AS | 12.05.2026 12 Monate | 12.05.2026 | 12 Monate | 298,50 270 | 298,50 | 270 | 9,547739 | JEFFERIES | ||
| Novo Nordisk AS | 11.05.2026 12 Monate | 11.05.2026 | 12 Monate | 298,50 175 | 298,50 | 175 | 41,373534 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 298,50 290 | 298,50 | 290 | 2,847571 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 0 Monate | 0 Monate | 298,50 290 | 298,50 | 290 | 2,847571 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 298,50 | 298,50 | -- | DZ BANK | |||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 298,50 300 | 298,50 | 300 | 0,502513 | BARCLAYS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 298,50 332 | 298,50 | 332 | 11,222781 | UBS | ||
| Novo Nordisk AS | 07.05.2026 0 Monate | 07.05.2026 | 0 Monate | 298,50 250 | 298,50 | 250 | 16,247906 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 06.05.2026 12 Monate | 06.05.2026 | 12 Monate | 298,50 263 | 298,50 | 263 | 11,892797 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 298,50 250 | 298,50 | 250 | 16,247906 | JPMORGAN | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 298,50 175 | 298,50 | 175 | 41,373534 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.05.2026 0 Monate | 06.05.2026 | 0 Monate | 298,50 300 | 298,50 | 300 | 0,502513 | BARCLAYS | ||
| Novo Nordisk AS | 29.04.2026 12 Monate | 29.04.2026 | 12 Monate | 298,50 250 | 298,50 | 250 | 16,247906 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 298,50 275 | 298,50 | 275 | 7,872697 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 298,50 270 | 298,50 | 270 | 9,547739 | JEFFERIES | ||
| Novo Nordisk AS | 20.04.2026 0 Monate | 20.04.2026 | 0 Monate | 298,50 250 | 298,50 | 250 | 16,247906 | JPMORGAN | ||
| Novo Nordisk AS | 15.04.2026 12 Monate | 15.04.2026 | 12 Monate | 298,50 270 | 298,50 | 270 | 9,547739 | JEFFERIES | ||
| Novo Nordisk AS | 09.04.2026 0 Monate | 09.04.2026 | 0 Monate | 298,50 332 | 298,50 | 332 | 11,222781 | UBS | ||
| Novo Nordisk AS | 01.04.2026 0 Monate | 01.04.2026 | 0 Monate | 298,50 270 | 298,50 | 270 | 9,547739 | BARCLAYS | ||
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 298,50 263 | 298,50 | 263 | 11,892797 | GOLDMAN SACHS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 298,50 270 | 298,50 | 270 | 9,547739 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 298,50 250 | 298,50 | 250 | 16,247906 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 298,50 275 | 298,50 | 275 | 7,872697 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 298,50 270 | 298,50 | 270 | 9,547739 | BARCLAYS | ||
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 298,50 250 | 298,50 | 250 | 16,247906 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 298,50 270 | 298,50 | 270 | 9,547739 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 298,50 270 | 298,50 | 270 | 9,547739 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 298,50 300 | 298,50 | 300 | 0,502513 | BERENBERG | ||
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 298,50 250 | 298,50 | 250 | 16,247906 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 298,50 270 | 298,50 | 270 | 9,547739 | BARCLAYS | ||
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 298,50 260 | 298,50 | 260 | 12,897822 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 298,50 270 | 298,50 | 270 | 9,547739 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 298,50 270 | 298,50 | 270 | 9,547739 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 298,50 400 | 298,50 | 400 | 34,00335 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 298,50 250 | 298,50 | 250 | 16,247906 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 298,50 400 | 298,50 | 400 | 34,00335 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 298,50 332 | 298,50 | 332 | 11,222781 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 298,50 340 | 298,50 | 340 | 13,902848 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 298,50 275 | 298,50 | 275 | 7,872697 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 298,50 350 | 298,50 | 350 | 17,252931 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 298,50 340 | 298,50 | 340 | 13,902848 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 298,50 275 | 298,50 | 275 | 7,872697 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 298,50 250 | 298,50 | 250 | 16,247906 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 298,50 270 | 298,50 | 270 | 9,547739 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 298,50 340 | 298,50 | 340 | 13,902848 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 298,50 340 | 298,50 | 340 | 13,902848 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 298,50 340 | 298,50 | 340 | 13,902848 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 298,50 340 | 298,50 | 340 | 13,902848 | BARCLAYS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 298,50 400 | 298,50 | 400 | 34,00335 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 298,50 275 | 298,50 | 275 | 7,872697 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 298,50 360 | 298,50 | 360 | 20,603015 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 298,50 360 | 298,50 | 360 | 20,603015 | BARCLAYS | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 298,50 360 | 298,50 | 360 | 20,603015 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 298,50 350 | 298,50 | 350 | 17,252931 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 298,50 332 | 298,50 | 332 | 11,222781 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 298,50 475 | 298,50 | 475 | 59,128978 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 298,50 332 | 298,50 | 332 | 11,222781 | UBS | ||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 298,50 350 | 298,50 | 350 | 17,252931 | JPMORGAN | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 298,50 270 | 298,50 | 270 | 9,547739 | JEFFERIES | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 298,50 350 | 298,50 | 350 | 17,252931 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 298,50 350 | 298,50 | 350 | 17,252931 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 298,50 360 | 298,50 | 360 | 20,603015 | BARCLAYS | ||
| Novo Nordisk AS | 01.02.2026 0 Monate | 01.02.2026 | 0 Monate | 298,50 390 | 298,50 | 390 | 30,653266 | UBS | ||
| Novo Nordisk AS | 29.01.2026 0 Monate | 29.01.2026 | 0 Monate | 298,50 350 | 298,50 | 350 | 17,252931 | JPMORGAN | ||
| Novo Nordisk AS | 23.01.2026 12 Monate | 23.01.2026 | 12 Monate | 298,50 270 | 298,50 | 270 | 9,547739 | JEFFERIES | ||
| Novo Nordisk AS | 22.01.2026 12 Monate | 22.01.2026 | 12 Monate | 298,50 436 | 298,50 | 436 | 46,063652 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 22.01.2026 0 Monate | 22.01.2026 | 0 Monate | 298,50 415 | 298,50 | 415 | 39,028476 | BERENBERG | ||
| Novo Nordisk AS | 21.01.2026 12 Monate | 21.01.2026 | 12 Monate | 298,50 360 | 298,50 | 360 | 20,603015 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 20.01.2026 12 Monate | 20.01.2026 | 12 Monate | 298,50 270 | 298,50 | 270 | 9,547739 | JEFFERIES | ||
| Novo Nordisk AS | 20.01.2026 0 Monate | 20.01.2026 | 0 Monate | 298,50 390 | 298,50 | 390 | 30,653266 | UBS | ||
| Novo Nordisk AS | 19.01.2026 0 Monate | 19.01.2026 | 0 Monate | 298,50 390 | 298,50 | 390 | 30,653266 | UBS | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 298,50 360 | 298,50 | 360 | 20,603015 | BARCLAYS |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 04.11.2026 | Bericht zum 3. Quartal Novo Nordisk A/S: Third quarter 2026 | Novo Nordisk A/S: Third quarter 2026 |
Anlage-Spezial Europäische Aktien
28.05.2026
Novo Nordisk: KI und Amycretin zünden nächste Pipeline-Stufe
KI beschleunigt die Wirkstoffforschung von Novo Nordisk erheblich. Neue Tabletten wie Amycretin sichern dabei die künftige Marktdominanz ab.
DZ BANK Produktauswahl
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Min
Discount in %
Max
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Mini-Futures Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M